98 filings
Page 2 of 5
8-K
d1wszg3coybe
19 May 20
Departure of Directors or Certain Officers
5:15pm
8-K
afthi18xbim4w615fzq
14 May 20
Other Events
5:00pm
8-K
1edxegmig492x8ptd1c0
20 Mar 20
Amendments to Articles of Incorporation or Bylaws
3:15pm
8-K
ebgj5o4xohk6 fi
11 Feb 20
Departure of Directors or Certain Officers
4:30pm
8-K
gq4fh5q26nwiojn
28 Jan 20
Entry into a Material Definitive Agreement
6:11am
8-K
5mufl3 wb
27 Jan 20
Nanoviricides Closes on $8.625 Million Underwritten Public Offering of Common Stock
5:12pm
8-K/A
ts9kv
2 Jan 20
Entry into a Material Definitive Agreement
12:39pm
8-K
poimh96fmlma5pfy9
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
opo5c5socgo0x neuyi
13 Dec 19
NanoViricides President Dr. Anil Diwan Provides Responses to Shareholder Questions at the Annual Meeting of Shareholders
5:19pm
8-K
7snr9zw6oxnth9
5 Nov 19
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
9:39pm
8-K
kg68wdil4o mu
26 Sep 19
Amendments to Articles of Incorporation or Bylaws
6:02am
8-K
0tgrhflw73b
1 Aug 19
Departure of Directors or Certain Officers
4:30pm
8-K
0q5m50y2 ckhy8vnnhk
10 Jun 19
Departure of Directors or Certain Officers
6:02am
8-K
u2ruh
1 Mar 19
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
6:11am
8-K
tku7k4owwp4zfk0ryp
1 Feb 19
Departure of Directors or Certain Officers
4:41pm
8-K
paydovr2cdcvi
7 Dec 18
Submission of Matters to a Vote of Security Holders
4:38pm
8-K
cmikp
31 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K/A
d8c0pc2k8xjt8
12 Sep 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
gwgctwi9i2b4tcgt5 xq
23 Jul 18
Entry into a Material Definitive Agreement
4:43pm
8-K
kyl9d w2g77ok2n6l7
19 Jul 18
Entry into a Material Definitive Agreement
12:00am